Arun BK - Search Results

1

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.

Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK, Hortobagyi GN, Do KA, Mills GB, Meric-Bernstam F. Gonzalez-Angulo AM, et al. Among authors: arun bk. Clin Cancer Res. 2011 Mar 1;17(5):1082-9. doi: 10.1158/1078-0432.CCR-10-2560. Epub 2011 Jan 13. Clin Cancer Res. 2011. PMID: 21233401 Free PMC article.

2

Survival after autologous hematopoietic stem cell transplantation for patients with inflammatory breast carcinoma.

Arun B, Slack R, Gehan E, Spitzer T, Meehan KR. Arun B, et al. Cancer. 1999 Jan 1;85(1):93-9. Cancer. 1999. PMID: 9921979

3

Progress in breast cancer chemoprevention.

Arun B, Hortobagyi GN. Arun B, et al. Endocr Relat Cancer. 2002 Mar;9(1):15-32. doi: 10.1677/erc.0.0090015. Endocr Relat Cancer. 2002. PMID: 11914180 Review.

4

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.

Esteva FJ, Valero V, Booser D, Guerra LT, Murray JL, Pusztai L, Cristofanilli M, Arun B, Esmaeli B, Fritsche HA, Sneige N, Smith TL, Hortobagyi GN. Esteva FJ, et al. J Clin Oncol. 2002 Apr 1;20(7):1800-8. doi: 10.1200/JCO.2002.07.058. J Clin Oncol. 2002. PMID: 11919237 Clinical Trial.

5

Molecular prognostic factors for breast cancer metastasis and survival.

Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN. Esteva FJ, et al. Semin Radiat Oncol. 2002 Oct;12(4):319-28. doi: 10.1053/srao.2002.35251. Semin Radiat Oncol. 2002. PMID: 12382190 Review.

6

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF. Pusztai L, et al. Clin Cancer Res. 2003 Jul;9(7):2406-15. Clin Cancer Res. 2003. PMID: 12855612

7

Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.

Rivera E, Valero V, Arun B, Royce M, Adinin R, Hoelzer K, Walters R, Wade JL 3rd, Pusztai L, Hortobagyi GN. Rivera E, et al. J Clin Oncol. 2003 Sep 1;21(17):3249-54. doi: 10.1200/JCO.2003.03.111. J Clin Oncol. 2003. PMID: 12947059 Clinical Trial.

8

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

Pusztai L, Zhen JH, Arun B, Rivera E, Whitehead C, Thompson WJ, Nealy KM, Gibbs A, Symmans WF, Esteva FJ, Booser D, Murray JL, Valero V, Smith TL, Hortobagyi GN. Pusztai L, et al. J Clin Oncol. 2003 Sep 15;21(18):3454-61. doi: 10.1200/JCO.2003.02.114. J Clin Oncol. 2003. PMID: 12972520 Clinical Trial.

9

Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.

Arun B, Kilic G, Yen C, Foster B, Yardley D, Gaynor R, Ashfaq R. Arun B, et al. Cancer. 2003 Dec 15;98(12):2554-9. doi: 10.1002/cncr.11853. Cancer. 2003. PMID: 14669273 Free article.

10

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.

Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN. Pusztai L, et al. Cytokine. 2004 Feb 7;25(3):94-102. doi: 10.1016/j.cyto.2003.10.004. Cytokine. 2004. PMID: 14698135 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

334 results

Search Page